Retractable Technologies, Inc.
Retractable Technologies, Inc. (NYSE American: RVP) manufactures and markets safety medical products, primarily syringes and needles, for healthcare providers. Its injection devices are sold under the VanishPoint®, EasyPoint® and Patient Safe® brands; many use automated needle retraction designed to reduce needlestick… From the company’s description.
Over the twelve months to Jun 30, 2026, Retractable Technologies, Inc. reported revenue of $33.90M, down 11.2% from a year earlier, and a net loss of $3.37M. Its operating margin was −66.9%, and operations used $4.95M in cash. In fiscal 2025, it reported revenue of $38.27M, up 15.8% from fiscal 2024, and a net loss of $12.57M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Retractable Technologies, Inc. does
In the company’s own words
Retractable Technologies, Inc. (NYSE American: RVP) manufactures and markets safety medical products, primarily syringes and needles, for healthcare providers. Its injection devices are sold under the VanishPoint®, EasyPoint® and Patient Safe® brands; many use automated needle retraction designed to reduce needlestick injuries and prevent reuse. VanishPoint® 1mL syringes also feature low dead space to reduce residual medication. In 2025, syringes represented 65.1% of sales and EasyPoint® products 31.2%; other products, including IV safety catheters and blood collection products, accounted for the remainder. The company sells mainly through U.S. general-line and specialty distributors, as well as international distributors, and also has a national direct-marketing network. It manufactures in Texas and uses manufacturers in China; its U.S. facility produced approximately 37.4% of units manufactured in 2025. The company had 201 employees as of March 9, 2026. Its website is www.retractable.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- LITTLE ELM, TX
- Fiscal year end
- December
- CIK
- 946563
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Retractable Technologies, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Retractable Technologies, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Retractable Technologies, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Retractable Technologies, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Retractable Technologies, Inc.'s last four quarterly filings that the numbers alone won't show?”